Nao Suzuki

ORCID: 0000-0002-7440-8127 · 12 papers in corpus
2025
Life (Basel, Switzerland) ·doi:10.3390/life15101609

Managing women with diminished ovarian reserve for in vitro fertilization (IVF) is challenging, often resulting in low oocyte yield and cycle failures. We hypothesize that coupling in vitro fertilization (IVF) with rescue in vitro maturatio…

2025
Biomedicines ·doi:10.3390/biomedicines13051084

Background/Objectives: Diminished ovarian reserve (DOR) poses significant challenges in the reproductive field, resulting in fewer mature and more low-quality eggs. Methods: We studied r-IVM in addition to standard in vitro fertilization (I…

other 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03478-6

The 8 th International Congress of the ISFP was held in Tokyo, Japan, from November 15 to 17, 2024. The theme of this year's Congress was "Rethinking Personalized Fertility Preservation and Cancer Survivors-Opening a New Frontier". The cong…

2024
Biology ·doi:10.3390/biology13120978

An overall in vitro fertilization (IVF) outcome is dynamic. Good oocyte quality is important for achieving a better IVF pregnancy. Various methods have been used for OQ assessment (OQA). However, due to inconclusive evidence, one method's s…

2023
Journal of gynecologic oncology ·doi:10.3802/jgo.2023.34.e1

ObjectivePreviously, we reported that insulinoma-associated protein 1 (INSM1) immunohistochemistry (IHC) showed high sensitivity for neuroendocrine carcinoma of the uterine cervix and was an effective method for histopathological diagnosis,…

article 2022
Analytical chemistry ·doi:10.1021/acs.analchem.1c04302

agglutinin (WFA)-reactive ceruloplasmin (CP) is a candidate marker for ovarian clear cell carcinoma (CCC) reported in our previous paper. Herein, a new measurement system was developed to investigate its potential as a serum marker for CCC.…

article 2020
·doi:10.1016/j.ejogrb.2020.10.014
2020
Journal of gynecologic oncology ·doi:10.3802/jgo.2020.31.e94

ObjectiveIn this study we sought to investigate the clinical factors that affect post-progression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer InterGroup d…

article 2016

Abstract PEGL-DOX is an excellent treatment for recurrent ovarian cancer that rarely causes side-effects like cardiotoxicity or hair loss, but frequently results in Hand-Foot Syndrome (HFS). In severe cases, it can become necessary to reduc…

article 2014
PloS one ·doi:10.1371/journal.pone.0098174

The primary objectives of the present study are to determine the period of onset of ovarian insufficiency after surgery and to confirm potential risk factors for ovarian insufficiency after surgery for the removal of benign ovarian cysts. D…

review 2011
·doi:10.1111/j.1447-0756.2010.01341.x

Formation of a fistula to a digestive organ is an extremely rare phenomenon in cases of ovarian carcinoma. We report a case of ovarian clear-cell carcinoma complicated by formation of a sigmoid colon fistula, and review the related literatu…

article 2005
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1111/j.1048-891x.2005.15004.x

A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two tumor markers can be detected by a combination immunoenzymometric assay of these two antigens. This combinatio…